This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Get an overview of common budgeting traps and why they happen. This intro explains prevention tips to keep your budget on track.
10,784 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The Fed’s decision to hold rates steady sent ripples through the market as inflation worries resurfaced. Here’s what ...
As AI accelerates, blue-collar automation could reshape factory floors. This piece examines which robotics stocks sta...
In a tightening insurance landscape, resilience upgrades are becoming the default. This report examines how builders ...
Palantir stock sits at a valuation well above the market average. This piece breaks down what that 2,500% gap means, ...
When headlines shout that Bitcoin is dead, smart investors reset the math. Here’s a practical plan to invest $500 tod...
Hycroft Mining stock dropped 18% this week as gold and silver prices slid and investors weighed development risk. Thi...
A major institutional move has trimmed a niche ETF position. Perritt Capital Management exited its Vanguard Internati...
When a stock plunges, investors face a fork in the road: fear or opportunity. This guide breaks down how to evaluate ...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
Across a century and a half, Western Union has defined cross-border payments. Yet fintech competition and shifting co...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...